Loading viewer...
investor_presentation
Format: PDF investor_presentation
1 Vale’s Performance in 1Q18Ricardo Teles / Agência Vale Rio de Janeiro, April 26th, 2018
Vale’s Performance in 1Q18Ricardo Teles / Agência Vale
Rio de Janeiro, April 26th, 2018
Agenda“This presentation may include statements thatpresent Vale's expectations about
future events orresults .Allstatements, when based upon expectations about the
future and notonhistorical facts, involve various risks and uncertainties .Vale
cannot guarantee that such statements willprove correct .These risks and
uncertainties include factors related tothefollowing :(a)thecountries where we
operate, especially Brazil and Canada ;(b)theglobal economy ;(c)thecapital
markets ;(d)themining and metals prices and their dependence onglobal
industrial production, which iscyclical bynature ;and(e)global competition inthe
markets inwhich Vale operates .Toobtain further information onfactors thatmay
lead toresults different from those forecast byVale, please consult thereports
Vale files with theU.S.Securities and Exchange Commission (SEC), the
Brazilian Comissão deValores Mobiliários (CVM), theFrench Autorité des
Marchés Financiers (AMF) and inparticular the factors discussed under
“Forward -Looking Statements” and“Risk Factors” inVale’s annual report onForm
“Cautionary Note toU.S.Investors -TheSEC permits mining companies, intheir
filings with theSEC, todisclose only those mineral deposits thatacompany can
economically and legally extract orproduce .Wepresent certain information in
thispresentation, including ‘measured resources,’ ‘indicated resources,’ ‘inferred
resources,’ ‘geologic resources’, which would notbepermitted inanSEC filing.
These materials arenotproven orprobable reserves, asdefined bytheSEC, and
wecannot assure you that these materials willbeconverted into proven or
probable reserves, asdefined bytheSEC.U.S.Investors should consider closely
thedisclosure inourAnnual Report onForm 20-K,which may beobtained from
us,from ourwebsite orathttp://http ://us.sec.gov/edgar .shtml .”
AgendaAgenda1.Vale’s performance in 1Q18
2.Capital expenditures
4.Business segment performance4Vale’s performance in
Total EBITDAPerformance highlights in 1Q185
Preview truncated — download the full document for the complete content.
investor_presentation
42 Pages
investor_presentation
33 Pages
Procter & Gamble
Basilea Pharmaceutica 2020 Investor Presentation
investor_presentationinvestor_presentation
27 Pages
Basilea Pharmaceutica International Ltd.
Southwest Gas Holdings Corporate Restructuring 2022
investor_presentationinvestor_presentation
11 Pages
Southwest Gas Holdings, Inc.